Gout, not induced by diuretics? A case-control study from primary care

被引:36
作者
Janssens, H. J. E. M.
de Lisdonk, E. H. van
Janssen, M.
van den Hoogen, H. J. M.
Verbeek, A. L. M.
机构
[1] Univ Nijmegen, Med Ctr, Dept Gen Practice & Family Med, NL-6500 HB Nijmegen, Netherlands
[2] Rijnstate Hosp, Dept Rheumatol, Arnhem, Netherlands
[3] Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands
关键词
D O I
10.1136/ard.2005.040360
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: It is taken for granted that diuretics may induce gout, but there is a general lack of evidence on this topic. Objectives: To determine the incidence of gout in patients who use diuretics, taking into account concurrent hypertension and cardiovascular diseases. Methods: A case-control study was designed. From a primary care population all patients with a first gout registration ( 59 men, 11 women; mean ( SD) age 55.1 ( 13.5)) were identified as cases. To relate the occurrence of gout to diuretic use a matched reference series of three controls for each case was compiled. Conditional logistic regression analyses were applied to estimate incidence rate ratios ( IRRs) of gout, and 95% confidence intervals ( CIs), in subjects with and without diuretic treatment, hypertension, and cardiovasculardiseases. Additional stratification analyses were made, particularly in the subjects not using diuretics. Results: The IRRs of gout in subjects with v those without diuretic treatment, hypertension, heart failure, and myocardial infarction were 2.8 ( 95% CI 1.2 to 6.6), 2.6 ( 95% CI 1.2 to 5.6), 20.9 ( 95% CI 2.5 to 173.8), and 1.9 ( 95% CI 0.7 to 4.7), respectively. After adjustment, the IRR of gout for diuretic use dropped to 0.6 ( 95% CI 0.2 to 2.0), while the IRRs of gout for hypertension, heart failure, and myocardial infarction were still > 1. This was also the case for subjects with hypertension or myocardial infarction, who had not used diuretics. Conclusion: The results suggest that diuretics do not actually increase the risk of gout. Cardiovascular indications for treatment may have confounded previous inferences.
引用
收藏
页码:1080 / 1083
页数:4
相关论文
共 34 条
[1]   GOUT AND CORONARY HEART-DISEASE - THE FRAMINGHAM-STUDY [J].
ABBOTT, RD ;
BRAND, FN ;
KANNEL, WB ;
CASTELLI, WP .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1988, 41 (03) :237-242
[2]   Uric acid and survival in chronic heart failure - Validation and application in metabolic, functional, and Hemodynamic staging [J].
Anker, SD ;
Doehner, W ;
Rauchhaus, M ;
Sharma, R ;
Francis, D ;
Knosalla, C ;
Davos, CH ;
Cicoira, M ;
Shamim, W ;
Kemp, M ;
Segal, R ;
Osterziel, KJ ;
Leyva, F ;
Hetzer, R ;
Ponikowski, P ;
Coats, AJS .
CIRCULATION, 2003, 107 (15) :1991-1997
[3]  
[Anonymous], AN THER CHEM CLASS S
[4]  
BERGLUND G, 1986, ACTA MED SCAND, V220, P419
[5]   On the brink of novel therapeutic options for an ancient disease [J].
Bieber, JD ;
Terkeltaub, RA .
ARTHRITIS AND RHEUMATISM, 2004, 50 (08) :2400-2414
[6]  
Chalmers J, 1999, J HYPERTENS, V17, P151
[7]  
*CLASS COMM WONCA, 1983, ICHPPC 2 DEF
[8]  
*COLL ZARGV, GEN INF PROJ
[9]  
*DUTCH COLL GEN PR, NHG STAND HYP HARTF
[10]   Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials [J].
Faris, R ;
Flather, M ;
Purcell, H ;
Henein, M ;
Poole-Wilson, P ;
Coats, A .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2002, 82 (02) :149-158